Safety/Efficacy Study of Rexin-G to Treat Pancreatic Cancer

Clinical trial NCT00504998 · COMPLETED

Trial details

NCT number: NCT00504998
Sponsor: Epeius Biotechnologies
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pancreatic Cancer

Start date: 2007-07-01
Primary completion: 2010-07-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.